Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease.
Bode M, Diemer JN, Luu TV, Ehnert N, Teigeler T, Wiech T, Lindenmeyer MT, Herrnstadt GR, Bülow J, Huber TB, Tomas NM, Wenzel UO.
Bode M, et al.
Br J Pharmacol. 2023 Sep;180(18):2412-2435. doi: 10.1111/bph.16097. Epub 2023 May 18.
Br J Pharmacol. 2023.
PMID: 37076314
Free article.